https://www.selleckchem.com/pr....oducts/emd-1214063.h
metastatic RMC. A metastatic PE-derived RMC PDX model was established and shown to maintain histologic features of the patient cancer. Molecular integrity of the PDX models was well maintained between renal tumor and PE PDX as well as between two successive renal tumor PDX generations. Using the PE PDX model, sunitinib demonstrated therapeutic efficacy for RMC. This model can serve as a foundation for future mechanistic and therapeutic studies for primary and metastatic RMC.Background Repeat hepatectomy is an important treatment for
Gefällt mir
Kommentar
Teilen
